Table 2 Saliva Aβ42 levels in patients with neurodegenerative diseases and control subjects
From: Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
Group | Aβ42 (pg/ml) | Aβ40 (pg/ml) | No. of subjects |
|---|---|---|---|
AD patients | 6.81 ± 20.04 | 22.3 ± 4.88 | 70 |
   Mild | 7.67 ± 16.25* | 21.87 ± 5.7 | 29 |
   Moderate | 11.70 ± 34.76 | 21.5 ± 4.17 | 24 |
   Severe | 3.03 ± 3.49 | 23.92 ± 4.55 | 17 |
PD patients | 3.66 ± 4.21 | 26.41 ± 5.12 | 51 |
Control subjects | 2.89 ± 4.96 | 20.82 ± 5.55 | 56 |